Oribel Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 102 |
|
|
2025
Q1 | – | Sell |
-47,400
| Closed | -$24.7M | – | 86 |
|
|
2024
Q4 | $24.7M | Buy |
+47,400
| New | +$24.7M | 0.84% | 21 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 75 |
|
|
2024
Q2 | – | Sell |
-20,500
| Closed | -$11.9M | – | 68 |
|
|
2024
Q1 | $11.9M | Sell |
20,500
-91,700
| -82% | -$53.3M | 0.7% | 23 |
|
|
2023
Q4 | $59.6M | Buy |
+112,200
| New | +$59.6M | 3.94% | 3 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 82 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 82 |
|
|
2023
Q1 | – | Sell |
-25,200
| Closed | -$13.9M | – | 80 |
|
|
2022
Q4 | $13.9M | Buy |
25,200
+11,500
| +84% | +$6.33M | 1.42% | 12 |
|
|
2022
Q3 | $6.95M | Buy |
13,700
+800
| +6% | +$406K | 0.94% | 21 |
|
|
2022
Q2 | $3.59M | Buy |
+12,900
| New | +$3.59M | 0.39% | 32 |
|
|
2022
Q1 | – | Sell |
-47,700
| Closed | -$31.8M | – | 133 |
|
|
2021
Q4 | $31.8M | Buy |
+47,700
| New | +$31.8M | 1.19% | 11 |
|